Maximize Market Research has published the “Global Biosimilar and Follow-on Biologics Market Report 2021”, which has covered the comprehensive analysis of market by different segment as well as demand & supply study and gaps between the same by region. The report gives an exclusive insights in key players by region with competitive landscape of the market. The market share in the industry is given by key players, which helps user of the report to understand the market structure at glance.

Key players in the industry are profiled in the report that give strategic insights of the companies with their top line and plans of expansion in near tern with M&A policies. Profiles of companies will help user to understand the most revenue generating segments for the companies including products, region.

Biosimilars are defined as a type of biological product that is similar to another drug, which has already been licensed (approved) by the US FDA or European Medicines Agency. The introduction of biosimilars to the market has created new opportunities as well the need for changes in practice within healthcare institutions.

The report has covered the market dynamics including demand drivers, restraints and opportunities by region. External factors and internal factors of companies affecting the growth of the companies and ultimately adding the total market are analysed in the report.

Global Biosimilar and Follow-on Biologics Market Key Competitors: The major players covered in the Biosimilar and Follow-on Biologics market report are

Global Biosimilar and Follow-on Biologics Market, By Region

• North America
• Europe
• Asia-Pacific
• MEA & Africa
• Latin America

Europe is expected to command largest market share of XX% by 2027.

Rising technological advancements in healthcare and the systematic drug review process will drive the markets from Europe. High patient awareness and regulatory harmonization dominate the biosimilar market in Europe.

Increasing funding for the development of biosimilar drugs, availability of high-quality research infrastructure, and strategies developed by drug makers to restrict the entry of new players are also the driving factors for the global market in Europe. Rising disease incidences in these countries are expected to prove favorable for the growth of the biosimilar drug market. A good example of this is Pfizer’s acquisition of Hospira, to gain access to the latter’s attractive biosimilars portfolio.

Key Players Operating in Global market includes

• Zydus Cadila
• Dr. Reddy’s Laboratories
• Emcure Pharmaceuticals
• Wockhardt
• Roche
• Quintiles
• Gennova
• Bayer
• AstraZeneca
• Hindustan Antibiotic
• Takeda
• GlaxoSmithKline
• Teva
• Syngene International
• Pfizer
• Johnson & Johnson
• Ortho Pharmaceutical
• Sanofi
• Merck KGaA
• Samsung BioLogics
• Ranbaxy Laboratories
• Novartis
• Novo Nordisk

Biosimilar and Follow-on Biologics Market report studies the top producers and consumers, focuses on product capacity, value, consumption, market share and growth opportunity in these key regions, covering

North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

About Maximize Market Research:

Maximize Market Research has served esteemed clients including Yamaha, Boeing, Sensata, Etnyre, Canada, ALCOR M&A, Microsoft, Harman, and other 200 MNCs worldwide. The Company provides B2B and B2C market research on 5000 high growth emerging technologies & opportunities in Transportation, Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defence and other manufacturing sectors. We, at Maximize Market Research, are a strong unified team of industry specialists and analysts across sectors to ensure entire Industry ecosystem is taken in perspective, factoring all recent development, latest trends and futuristic – the technological impact of uniquely specific industries. In line with the agreed scope and objective of the study, our approach is uniquely custom detailed.

Contact Us:

Maximize Market Research Pvt ltd.